Endo International PLC (ENDP) Shares Bought by Nationwide Fund Advisors

Nationwide Fund Advisors grew its stake in shares of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 4.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 360,787 shares of the company’s stock after acquiring an additional 16,913 shares during the period. Nationwide Fund Advisors owned 0.16% of Endo International PLC worth $4,030,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. HL Financial Services LLC grew its holdings in shares of Endo International PLC by 1.0% during the 2nd quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock valued at $590,000 after acquiring an additional 500 shares in the last quarter. Amalgamated Bank grew its holdings in shares of Endo International PLC by 2.0% during the 1st quarter. Amalgamated Bank now owns 32,357 shares of the company’s stock valued at $361,000 after acquiring an additional 619 shares in the last quarter. Meeder Asset Management Inc. grew its holdings in shares of Endo International PLC by 1.4% during the 2nd quarter. Meeder Asset Management Inc. now owns 48,699 shares of the company’s stock valued at $544,000 after acquiring an additional 677 shares in the last quarter. Capstone Asset Management Co. grew its holdings in shares of Endo International PLC by 3.1% during the 2nd quarter. Capstone Asset Management Co. now owns 32,035 shares of the company’s stock valued at $358,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System grew its holdings in shares of Endo International PLC by 1.5% during the 2nd quarter. Arizona State Retirement System now owns 83,700 shares of the company’s stock valued at $935,000 after acquiring an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 90.71% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2017/10/09/endo-international-plc-endp-shares-bought-by-nationwide-fund-advisors.html.

Several research firms have recently commented on ENDP. Guggenheim began coverage on shares of Endo International PLC in a report on Saturday, June 17th. They set a “hold” rating and a $12.00 price target on the stock. Canaccord Genuity set a $10.00 price target on shares of Endo International PLC and gave the company a “hold” rating in a report on Monday, August 14th. Deutsche Bank AG lowered their price target on shares of Endo International PLC from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, July 7th. Royal Bank Of Canada restated a “sector perform” rating and set a $9.00 price target (down from $15.00) on shares of Endo International PLC in a report on Wednesday, August 9th. Finally, Cowen and Company restated a “hold” rating and set a $16.00 price target on shares of Endo International PLC in a report on Thursday, August 10th. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and five have issued a buy rating to the company’s stock. Endo International PLC has an average rating of “Hold” and an average target price of $12.80.

Shares of Endo International PLC (ENDP) opened at 8.58 on Monday. Endo International PLC has a 1-year low of $7.41 and a 1-year high of $21.87. The company has a 50 day moving average of $8.69 and a 200 day moving average of $10.61. The firm’s market cap is $1.92 billion.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last released its earnings results on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.19. The business had revenue of $875.73 million during the quarter, compared to the consensus estimate of $832.66 million. Endo International PLC had a negative net margin of 126.93% and a positive return on equity of 37.58%. The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.86 earnings per share. On average, equities analysts forecast that Endo International PLC will post $3.52 earnings per share for the current fiscal year.

In other Endo International PLC news, CFO Blaise Coleman bought 6,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was acquired at an average price of $7.89 per share, with a total value of $51,285.00. Following the completion of the transaction, the chief financial officer now owns 13,729 shares in the company, valued at $108,321.81. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Terrance J. Coughlin bought 20,000 shares of the firm’s stock in a transaction that oc

Several other institutional investors also recently bought and sold shares of the company. HL Financial Services LLC grew its holdings in shares of Endo International PLC by 1.0% during the 2nd quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock valued at $590,000 after acquiring an additional 500 shares in the last quarter. Amalgamated Bank grew its holdings in shares of Endo International PLC by 2.0% during the 1st quarter. Amalgamated Bank now owns 32,357 shares of the company’s stock valued at $361,000 after acquiring an additional 619 shares in the last quarter. Meeder Asset Management Inc. grew its holdings in shares of Endo International PLC by 1.4% during the 2nd quarter. Meeder Asset Management Inc. now owns 48,699 shares of the company’s stock valued at $544,000 after acquiring an additional 677 shares in the last quarter. Capstone Asset Management Co. grew its holdings in shares of Endo International PLC by 3.1% during the 2nd quarter. Capstone Asset Management Co. now owns 32,035 shares of the company’s stock valued at $358,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System grew its holdings in shares of Endo International PLC by 1.5% during the 2nd quarter. Arizona State Retirement System now owns 83,700 shares of the company’s stock valued at $935,000 after acquiring an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 90.71% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2017/10/09/endo-international-plc-endp-shares-bought-by-nationwide-fund-advisors.html.

Several research firms have recently commented on ENDP. Guggenheim began coverage on shares of Endo International PLC in a report on Saturday, June 17th. They set a “hold” rating and a $12.00 price target on the stock. Canaccord Genuity set a $10.00 price target on shares of Endo International PLC and gave the company a “hold” rating in a report on Monday, August 14th. Deutsche Bank AG lowered their price target on shares of Endo International PLC from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, July 7th. Royal Bank Of Canada restated a “sector perform” rating and set a $9.00 price target (down from $15.00) on shares of Endo International PLC in a report on Wednesday, August 9th. Finally, Cowen and Company restated a “hold” rating and set a $16.00 price target on shares of Endo International PLC in a report on Thursday, August 10th. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and five have issued a buy rating to the company’s stock. Endo International PLC has an average rating of “Hold” and an average target price of $12.80.

Shares of Endo International PLC (ENDP) opened at 8.58 on Monday. Endo International PLC has a 1-year low of $7.41 and a 1-year high of $21.87. The company has a 50 day moving average of $8.69 and a 200 day moving average of $10.61. The firm’s market cap is $1.92 billion.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last released its earnings results on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.19. The business had revenue of $875.73 million during the quarter, compared to the consensus estimate of $832.66 million. Endo International PLC had a negative net margin of 126.93% and a positive return on equity of 37.58%. The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.86 earnings per share. On average, equities analysts forecast that Endo International PLC will post $3.52 earnings per share for the current fiscal year.

In other Endo International PLC news, CFO Blaise Coleman bought 6,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was acquired at an average price of $7.89 per share, with a total value of $51,285.00. Following the completion of the transaction, the chief financial officer now owns 13,729 shares in the company, valued at $108,321.81. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Terrance J. Coughlin bought 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was acquired at an average cost of $7.70 per share, with a total value of $154,000.00. Following the transaction, the chief operating officer now owns 181,369 shares of the company’s stock, valued at approximately $1,396,541.30. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 36,000 shares of company stock valued at $279,460. 0.50% of the stock is owned by insiders.

Endo International PLC Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply